The U.S. Senate is headed back into the fray with a bill that would create a national drug tracking system. The proposed law would mandate the tracking of many drugs by manufacturers in four years but would not require manufacturers or distributors to be able to trace single units for a decade. It is a far cry from the "real-time" tracking the FDA wanted instituted much sooner but industry resistance to that language kept it out of last year's Food and Drug Administration Safety and Innovation Act, Regulatory Focus points out. The industry may be ready to give a little though to prevent states from putting in stricter regulations than it wants to face. California is set to require unit level tracking in 2015 but the Senate bill would override any state laws. Story | More